Guidance, NICE advice and quality standards in development

Showing 341 to 350 of 383

Sort by

Guidance, NICE advice and quality standards in development
Title	Type	Expected publication date
Tenecteplase for treating acute ischaemic stroke [ID6306]	Technology appraisal guidance	TBC
Third molars (impacted) - prophylactic removal [ID898]	Technology appraisal guidance	TBC
Tirzepatide for managing overweight and obesity [ID6179]	Technology appraisal guidance	19 June 2024
Tislelizumab for previously treated advanced oesophageal squamous cell cancer [ID4070]	Technology appraisal guidance	TBC
Tislelizumab for treating advanced non-small-cell lung cancer after platinum-based chemotherapy [ID6161]	Technology appraisal guidance	TBC
Tislelizumab in combination for untreated advanced non-small-cell lung cancer [ID6162]	Technology appraisal guidance	TBC
Tisotumab vedotin for treating recurrent or metastatic cervical cancer after systemic therapy [ID3753]	Technology appraisal guidance	TBC
Topical Antimicrobial dressings for wound care: Late stage assessment	Health technology evaluation	TBC
Topical rapamycin for treating facial angiofibromas associated with tuberous sclerosis complex in people 6 years and over [ID6391]	Technology appraisal guidance	TBC
Total hip arthroplasty using the superpath approach for osteoarthritis	Interventional procedures guidance	TBC